infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 39 articles.

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Elevated HBV surface antigen, viral load increases liver cancer risk

    Healio Hepatology / 06 December 2017

  • HCV clearance lowers liver cancer risk by 70% no matter drug of choice

    Healio / 25 October 2017

  • Deaths Rates of Liver Cirrhosis Exceed Those of 5 Major Cancers

    AASLD / 23 October 2017

  • Age, comorbidities greater impact on HCC rates than DAA therapy

    Healio Hepatology / 23 October 2017

  • Liver disease risk may be heightened by gastric acid drugs

    Liver Disease News from Medical News Today / 11 October 2017

  • NASH: It's Fibrosis, Not Fat, that Matters

    MedPage Today Gastroenterology / 21 April 2017

  • Nivolumab produces durable responses & long-term survival in severe liver cancer patients

    Eurekalert Inf Dis / 21 April 2017

  • HCV Infection Linked to Nonhepatic Cancers in the Elderly

    Infectious Disease Advisor / 21 February 2017

  • Nearly one-third of patients with previous HCC recur after DAA therapy

    Healio Hepatology / 15 April 2016

  • Australia: Treatment Has Changed campaign

    Hepatitis New South Wales / 17 February 2016

← Prev1234Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//